Unlocking the Secrets of Peptide Aggregation: A Boost for Drug Stability and Material Science

Scientists have shed light on how short peptide chains aggregate, enhancing our understanding of a process crucial for drug stability and material development.

Peptides, which are short chains of amino acids, play critical roles in biological processes by constructing structures, catalysing chemical reactions, and supporting the immune system. The specific functions of these proteins are determined by the way their amino acids interact and aggregate into three-dimensional structures.

A team of researchers from China has explored how short peptide chains, specifically tetrapeptides and pentapeptides, aggregate based on their amino acid sequences. Published in JACS Au, the study employed molecular dynamics simulations and advanced AI techniques to predict peptide behaviour. By examining 160,000 tetrapeptides and 3.2 million pentapeptides, the scientists discovered patterns in how certain amino acids promote or inhibit aggregation.

Key Findings: Aromatic and Hydrophilic Influences

The study found that aromatic amino acids, such as tryptophan, phenylalanine, and tyrosine, significantly enhance aggregation, particularly when positioned towards the C-terminus of the peptide chain. This is attributed to “π-π” interactions—attractive forces between the ring-shaped structures of aromatic amino acids. In contrast, hydrophilic amino acids like aspartic acid and glutamic acid were found to inhibit aggregation, as their strong interaction with water molecules prevents peptides from clumping together.

Furthermore, the researchers demonstrated that altering the amino acid sequence can change how peptides aggregate. For example, adding aromatic amino acids to the peptide chain’s end increases aggregation, while negatively charged amino acids at the start reduce it. The study also revealed that the types and positions of amino acids influence the shapes formed by peptide aggregates, ranging from long, thread-like structures to round, ball-like clusters.

Applications in Medicine and Technology

These insights into peptide aggregation have significant implications for various fields. “Understanding how tetrapeptides stick to each other allows us to predict the behaviour of longer peptides, simplifying the design of more stable drugs and materials,” explains Dr Wenbin Li, an assistant professor at Westlake University and corresponding author of the study. This knowledge is valuable for designing new materials, developing stable drug delivery systems, and understanding diseases linked to peptide aggregation, such as Alzheimer’s disease.

Dr Jiaqi Wang, an assistant professor at Xi’an Jiaotong-Liverpool University and the study’s first author, highlighted the potential for biotechnology applications: “By providing new insights into peptide aggregation, this research will advance biochemistry, materials science, and computational biology, leading to breakthroughs in medical treatments, eco-friendly products, and innovative technologies.”

For further information on the study, you can access the full publication in JACS Au.